Rck/p54 interacts with APP mRNA as part of a multi-protein complex and enhances APP mRNA and protein expression in neuronal cell lines

Neurobiology of Aging

Volumn 30, Issue 12, 2009, Pages 1962-1974

  Broytman, Oleg ^a   Westmark, Pamela R ^a   Gurel, Zafer ^a   Malter, James S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Amyloid precursor protein; 3 UTR regulatory elements; Alzheimer's disease; rck p54

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DEAD BOX PROTEIN; ELONGATION FACTOR 1ALPHA; LA ANTIBODY; LA ANTIGEN; NUCLEOLIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN P54; RNA BINDING PROTEIN; Y BOX BINDING PROTEIN 1;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; REGULATORY SEQUENCE; TRANSCRIPTION REGULATION;

3' UNTRANSLATED REGIONS; AMYLOID BETA-PROTEIN PRECURSOR; BINDING SITES; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICROSCOPY, CONFOCAL; NEURONS; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TRANSFECTION;

EID: 70349984421     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.02.011     Document Type: Article

References (47)

1. Akao Y., Marukawa O., Morikawa H., Nakao K., Kamei M., Hachiya T., and Tsujimoto Y. The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues. Cancer Res. 55 (1995) 3444-3449
2. Akao Y., Yoshida H., Matsumoto K., Matsui T., Hogetu K., Tanaka N., and Usukura J. A tumour-associated DEAD-box protein, rck/p54 exhibits RNA unwinding activity toward c-myc RNAs in vitro. Genes Cells 8 (2003) 671-676
3. Amara F.M., Junaid A., Clough R.R., and Liang B. TGF-beta(1), regulation of alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization. Brain Res. Mol. Brain Res. 71 (1999) 42-49
4. Balbach J.J., Ishii Y., Antzutkin O.N., Leapman R.D., Rizzo N.W., Dyda F., Reed J., and Tycko R. Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39 (2000) 13748-13759
5. Braak H., and Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol. Scand. Suppl. 165 (1996) 3-12
6. Braak H., and Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16 (1995) 271-278 (Discussion 278-284)
7. Buckland P., Tidmarsh S., Spurlock G., Kaiser F., Yates M., O'Mahony G., and McGuffin P. Amyloid precursor protein mRNA levels in the mononuclear blood cells of Alzheimer's and Down's patients. Brain Res. Mol. Brain Res. 18 (1993) 316-320
8. Capowski E.E., Esnault S., Bhattacharya S., and Malter J.S. Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J. Immunol. 167 (2001) 5970-5976
9. Chan E.K., and Tan E.M. Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies. J. Exp. Med. 166 (1987) 1627-1640
10. Chao H.M., Spencer R.L., Frankfurt M., and McEwen B.S. The effects of aging and hormonal manipulation on amyloid precursor protein APP695 mRNA expression in the rat hippocampus. J. Neuroendocrinol. 6 (1994) 517-521
11. Chu C.Y., and Rana T.M. Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol. 4 (2006) e210
12. Coller J., and Parker R. General translational repression by activators of mRNA decapping. Cell 122 (2005) 875-886
13. Coller J.M., Tucker M., Sheth U., Valencia-Sanchez M.A., and Parker R. The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes. RNA 7 (2001) 1717-1727
14. Engmann L., Losel R., Wehling M., and Peluso J.J. Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism. J. Clin. Endocrinol. Metab. 91 (2006) 4962-4968
15. Greenfield J.P., Tsai J., Gouras G.K., Hai B., Thinakaran G., Checler F., Sisodia S.S., Greengard P., and Xu H. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 742-747
16. Heaton J.H., Dlakic W.M., Dlakic M., and Gelehrter T.D. Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the Type-1 plasminogen activator inhibitor mRNA. J. Biol. Chem. 276 (2001) 3341-3347
17. Heaton J.H., Dlakic W.M., and Gelehrter T.D. Posttranscriptional regulation of PAI-1 gene expression. Thromb. Haemost. 89 (2003) 959-966
18. Higgins G.A., Lewis D.A., Bahmanyar S., Goldgaber D., Gajdusek D.C., Young W.G., Morrison J.H., and Wilson M.C. Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 1297-1301
19. Ivanov A.V., Malygin A.A., and Karpova G.G. Human ribosomal protein S26 suppresses the splicing of its pre-mRNA. Biochim. Biophys. Acta 1727 (2005) 134-140
20. Marco E., Martin-Santamaria S., Cuevas C., and Gago F. Structural basis for the binding of didemnins to human elongation factor eEF1A and rationale for the potent antitumor activity of these marine natural products. J. Med. Chem. 47 (2004) 4439-4452
21. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
22. Mattson M.P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77 (1997) 1081-1132
23. McLaren R.S., Caruccio N., and Ross J. Human La protein: a stabilizer of histone mRNA. Mol. Cell. Biol 17 (1997) 3028-3036
24. Neupert B., Thompson N.A., Meyer C., and Kuhn L.C. A high yield affinity purification method for specific RNA-binding proteins: isolation of the iron regulatory factor from human placenta. Nucleic Acids Res. 18 (1990) 51-55
25. Neve R.L., Finch E.A., and Dawes L.R. Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron 1 (1988) 669-677
26. Oyama F., Cairns N.J., Shimada H., Oyama R., Titani K., and Ihara Y. Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination. J. Neurochem. 62 (1994) 1062-1066
27. Palmert M.R., Golde T.E., Cohen M.L., Kovacs D.M., Tanzi R.E., Gusella J.F., Usiak M.F., Younkin L.H., and Younkin S.G. Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease. Science 241 (1988) 1080-1084
28. Parker R., and Song H. The enzymes and control of eukaryotic mRNA turnover. Nat. Struct. Mol. Biol. 11 (2004) 121-127
29. Peluso J.J., Pappalardo A., Losel R., and Wehling M. Expression and function of PAIRBP1 within gonadotropin-primed immature rat ovaries: PAIRBP1 regulation of granulosa and luteal cell viability. Biol. Reprod. 73 (2005) 261-270
30. Pike C.J., Overman M.J., and Cotman C.W. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J. Biol. Chem. 270 (1995) 23895-23898
31. Pinol-Roma S., Swanson M.S., Matunis M.J., and Dreyfuss G. Purification and characterization of proteins of heterogeneous nuclear ribonucleoprotein complexes by affinity chromatography. Methods Enzymol. 181 (1990) 326-331
32. Pruijn G.J., Thijssen J.P., Smith P.R., Williams D.G., and Van Venrooij W.J. Anti-La monoclonal antibodies recognizing epitopes within the RNA-binding domain of the La protein show differential capacities to immunoprecipitate RNA-associated La protein. Eur. J. Biochem. 232 (1995) 611-619
33. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., and Masters C.L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med 320 (1989) 1446-1452
34. Sandbrink R., Banati R., Masters C.L., Beyreuther K., and Konig G. Expression of L-APP mRNA in brain cells. Ann. N. Y. Acad. Sci. 695 (1993) 183-189
35. Sengupta T.K., Bandyopadhyay S., Fernandes D.J., and Spicer E.K. Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J. Biol. Chem. 279 (2004) 10855-10863
36. Singh K., Laughlin J., Kosinski P.A., and Covey L.R. Nucleolin is a second component of the CD154 mRNA stability complex that regulates mRNA turnover in activated T cells. J. Immunol. 173 (2004) 976-985
37. Swanson M.S., and Dreyfuss G. Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities. Mol. Cell. Biol. 8 (1988) 2237-2241
38. Tanner N.K., and Linder P. DExD/H box RNA helicases: from generic motors to specific dissociation functions. Mol. Cell 8 (2001) 251-262
39. Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A., St George-Hyslop P., Van Keuren M.L., Patterson D., Pagan S., Kurnit D.M., and Neve R.L. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235 (1987) 880-884
40. Vocero-Akbani A., Lissy N.A., and Dowdy S.F. Transduction of full-length Tat fusion proteins directly into mammalian cells: analysis of T cell receptor activation-induced cell death. Methods Enzymol. 322 (2000) 508-521
41. Westmark C.J., and Malter J.S. Extracellular-regulated kinase controls beta-amyloid precursor protein mRNA decay. Brain Res. Mol. Brain Res. 90 (2001) 193-201
42. Westmark P.R., Shin H.C., Westmark C.J., Soltaninassab S.R., Reinke E.K., and Malter J.S. Decoy mRNAs reduce beta-amyloid precursor protein mRNA in neuronal cells. Neurobiol. Aging 27 (2006) 787-796
43. Weston A., and Sommerville J. Xp54 and related (DDX6-like) RNA helicases: roles in messenger RNP assembly, translation regulation and RNA degradation. Nucleic Acids Res. 34 (2006) 3082-3094
44. Wojtal K., Trojnar M.K., and Czuczwar S.J. Endogenous neuroprotective factors: neurosteroids. Pharmacol. Rep. 58 (2006) 335-340
45. Zaidi S.H., Denman R., and Malter J.S. Multiple proteins interact at a unique cis-element in the 3′-untranslated region of amyloid precursor protein mRNA. J. Biol. Chem. 269 (1994) 24000-24006
46. Zaidi S.H., and Malter J.S. Nucleolin and heterogeneous nuclear ribonucleoprotein C proteins specifically interact with the 3′-untranslated region of amyloid protein precursor mRNA. J. Biol. Chem. 270 (1995) 17292-17298
47. Zaidi S.H., and Malter J.S. Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3′-untranslated region. J. Biol. Chem. 269 (1994) 24007-24013